UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Mechanisms and Treatment of Intradialytic Hypertension - Sodium
Completed
- Conditions
- HypertensionIntradialytic HypertensionEnd-stage Renal DiseaseHemodialysis
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT01371890
- Locations
- 🇺🇸
UT Southwestern, Dallas, Texas, United States
Effect of Dietary Macronutrient Composition
Not Applicable
Completed
- Conditions
- Metabolic SyndromeObesityNon-alcoholic Fatty Liver Disease
- Interventions
- Other: Low-fat dietOther: Low-carbohydrate diet
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01371396
- Locations
- 🇺🇸
Center for Human Nutrition, Dallas, Texas, United States
Effects of IGF-I in HIV Metabolic Disease
- First Posted Date
- 2011-04-06
- Last Posted Date
- 2016-03-23
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01329744
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Antidepressant Treatment at an Inner City Asthma Clinic
Phase 4
Completed
- Conditions
- DepressionAsthma
- First Posted Date
- 2011-03-29
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 139
- Registration Number
- NCT01324700
- Locations
- 🇺🇸
Parkland Health and Hospital System (Asthma, Allergy, & Arthritis Clinics), Dallas, Texas, United States
Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01321151
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
Phase 1
Withdrawn
- Conditions
- Stage II Rectal CancerStage III Rectal Cancer
- Interventions
- Radiation: radiationProcedure: total mesorectal excision
- First Posted Date
- 2011-02-24
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT01302613
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Metastatic CancerLung Cancer
- Interventions
- Combination Product: (Erlotinib plus Romidepsin (8mg/m^2)) + Antiemetic prophylaxisCombination Product: Erlotinib plus Romidepsin (10 mg/m^2)Combination Product: Erlotinib plus Romidepsin (8 mg/m^2)Combination Product: Erlotinib plus Romidepsin (10 mg/m^2) + Antiemetic prophylaxis
- First Posted Date
- 2011-02-24
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 17
- Registration Number
- NCT01302808
- Locations
- 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
Reliability and Diagnostic Accuracy of an Alternate Lachman's Test Performed in a Prone Position
Completed
- Conditions
- Anterior Cruciate Ligament Stability
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 57
- Registration Number
- NCT01301014
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
Not Applicable
Terminated
- Conditions
- Moderate to Severe Atopic Dermatitis
- Interventions
- Other: Dilute bleach bathsOther: Water
- First Posted Date
- 2011-01-31
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT01286220
- Locations
- 🇺🇸
Children's Medical Center of Dallas, Dallas, Texas, United States
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
Not Applicable
Completed
- Conditions
- Portosystemic EncephalopathyPSEHepatic EncephalopathyCirrhosis
- Interventions
- Drug: Polyethylene glycol 3350-electrolyte solution (GoLYTELY®)
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01283152
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center and Parkland Memorial Health and Hospital System, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath